Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $mnpr

Monopar Therapeutics (MNPR) sees a significant surge in social engagements, up XXXXX% week-over-week, driven by positive sentiment around stock performance and drug development. Analysts are issuing outperform ratings with price targets as high as $XXX.

### About $mnpr
Monopar Therapeutics (MNPR) is a biotechnology company focused on developing treatments for rare diseases.  

### Insights
- $mnpr engagements is up XXXXX% from the previous week.

### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$mnpr/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$mnpr/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXX  
X Week: XXXXX +26%  
X Month: XXXXXX -XX%  
X Months: XXXXXXX +23%  
X Year: XXXXXXXXX -XX%  
1-Year High: XXXXXXX on 2025-10-20  
1-Year Low: XX on 2025-06-15  

Engagements by network (24h):
X: XXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$mnpr/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$mnpr/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX -XX%  
X Months: XXXXX +487%  
X Year: XXXXX +232%  
1-Year High: XXX on 2025-08-27  
1-Year Low: X on 2025-12-07  

Mentions by network (24h):
X: XX

  
  
### Creators: X (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$mnpr/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$mnpr/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $mnpr in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: XX  
X Week: XX -XX%  
X Month: XX -XX%  
X Months: XXXXX +1,464%  
X Year: XXXXX +551%  
1-Year High: XXX on 2025-08-27  
1-Year Low: X on 2025-12-07  

The most influential creators that mention $mnpr in the last XX hours

| Creator                                        | Rank | Followers | Posts | Engagements |
| -------                                        | ---- | --------- | ----- | ----------- |
| [@kjerath](/creator/twitter/kjerath)           | X    | XXX       | X     | XX          |
| [@notreload_ai](/creator/twitter/notreload_ai) | X    | XXXXX     | X     | X           |

[View More](/list/creators/$mnpr/100)
  
  
### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$mnpr/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$mnpr/time-series/sentiment.tsv)  
Current Value: XXX%  
Daily Average: XX%  
X Week: XXX% no change  
X Month: XXX% no change  
X Months: XXX% +50%  
X Year: XXX% no change  
1-Year High: XXX% on 2025-01-22  
1-Year Low: XX% on 2025-07-25  

Most Supportive Themes:
- Stock Performance and Investment Potential: (40%) Posts highlight Monopar Therapeutics (MNPR) as a top performer and a potential investment, citing significant percentage gains and analyst target raises.
- Biotech Drug Development and Approvals: (30%) Discussions focus on Monopar's drug development, particularly for Wilson disease, and the potential for FDA approval, indicating significant progress and future prospects.
- Market Trends and Mentions in Hype Cycles: (20%) MNPR is frequently mentioned alongside other trending stocks during periods of high social media hype, suggesting its inclusion in broader market discussions and speculative interest.
  
Most Critical Themes:
- Past Development Setbacks and Acquisition: (10%) While positive, some posts allude to the drug's history, including AstraZeneca's termination of development due to an 'inadvertent error,' which Monopar later acquired and corrected.
  

### Top $mnpr Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$SUGP hype is insane like the prime days of SMX $HKD $TOP $GME $DJT $PHUN $HOLO $MLGO $FFAI $AMC $NEGG $CVNA $MNPR $NUKK"  
[X Link](https://x.com/Jokerparabol/status/1998527543180484784) [@Jokerparabol](/creator/x/Jokerparabol) 2025-12-09T22:57Z 6610 followers, XXX engagements


"$MNPR $NVDA $MLGO To Analyst price target for next week-"  
[X Link](https://x.com/Chat3Free/status/1998392787520368867) [@Chat3Free](/creator/x/Chat3Free) 2025-12-09T14:02Z XXX followers, XX engagements


"$ONDS šŸ”„Major Money Deals IncomingšŸ”„ $FCX $FDS $FE $FFIV $FICO $FIS $FISV $FITB $FOX $FOXA $FRT $FSLR $FTNT $FTV $GDDY $GEHC $GEN $GILD $GIS $MAJI $MEDCL $MGOL $MGX $GLW $GM $GNRC $GOOG $GPC $GPN $GRMN $GS $GWW $HAL $HAS $HBAN $HCA $MNPR $MODG $MSO $NOW"  
[X Link](https://x.com/Newbie_AAA/status/1998113474870997300) [@Newbie_AAA](/creator/x/Newbie_AAA) 2025-12-08T19:32Z XX followers, XXX engagements


"for data since NXP-800 failed because if NXP-900 works it doesn't matter if they buy at $X or $XX or $XX - it's still a home run. But at $X the potential for $NVCT is similar to $AXSM and $MNPR in terms of returns. Now management must deliver"  
[X Link](https://x.com/kjerath/status/1996217652214202535) [@kjerath](/creator/x/kjerath) 2025-12-03T13:59Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$mnpr

Monopar Therapeutics (MNPR) sees a significant surge in social engagements, up XXXXX% week-over-week, driven by positive sentiment around stock performance and drug development. Analysts are issuing outperform ratings with price targets as high as $XXX.

About $mnpr

Monopar Therapeutics (MNPR) is a biotechnology company focused on developing treatments for rare diseases.

Insights

  • $mnpr engagements is up XXXXX% from the previous week.

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX +26%
X Month: XXXXXX -XX%
X Months: XXXXXXX +23%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-10-20
1-Year Low: XX on 2025-06-15

Engagements by network (24h): X: XXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXXXX +487%
X Year: XXXXX +232%
1-Year High: XXX on 2025-08-27
1-Year Low: X on 2025-12-07

Mentions by network (24h): X: XX

Creators: X (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $mnpr in the last XX hours which is down XX% from X in the previous XX hours Daily Average: XX
X Week: XX -XX%
X Month: XX -XX%
X Months: XXXXX +1,464%
X Year: XXXXX +551%
1-Year High: XXX on 2025-08-27
1-Year Low: X on 2025-12-07

The most influential creators that mention $mnpr in the last XX hours

Creator Rank Followers Posts Engagements
@kjerath X XXX X XX
@notreload_ai X XXXXX X X

View More

Sentiment: XXX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% no change
X Months: XXX% +50%
X Year: XXX% no change
1-Year High: XXX% on 2025-01-22
1-Year Low: XX% on 2025-07-25

Most Supportive Themes:

  • Stock Performance and Investment Potential: (40%) Posts highlight Monopar Therapeutics (MNPR) as a top performer and a potential investment, citing significant percentage gains and analyst target raises.
  • Biotech Drug Development and Approvals: (30%) Discussions focus on Monopar's drug development, particularly for Wilson disease, and the potential for FDA approval, indicating significant progress and future prospects.
  • Market Trends and Mentions in Hype Cycles: (20%) MNPR is frequently mentioned alongside other trending stocks during periods of high social media hype, suggesting its inclusion in broader market discussions and speculative interest.

Most Critical Themes:

  • Past Development Setbacks and Acquisition: (10%) While positive, some posts allude to the drug's history, including AstraZeneca's termination of development due to an 'inadvertent error,' which Monopar later acquired and corrected.

Top $mnpr Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$SUGP hype is insane like the prime days of SMX $HKD $TOP $GME $DJT $PHUN $HOLO $MLGO $FFAI $AMC $NEGG $CVNA $MNPR $NUKK"
X Link @Jokerparabol 2025-12-09T22:57Z 6610 followers, XXX engagements

"$MNPR $NVDA $MLGO To Analyst price target for next week-"
X Link @Chat3Free 2025-12-09T14:02Z XXX followers, XX engagements

"$ONDS šŸ”„Major Money Deals IncomingšŸ”„ $FCX $FDS $FE $FFIV $FICO $FIS $FISV $FITB $FOX $FOXA $FRT $FSLR $FTNT $FTV $GDDY $GEHC $GEN $GILD $GIS $MAJI $MEDCL $MGOL $MGX $GLW $GM $GNRC $GOOG $GPC $GPN $GRMN $GS $GWW $HAL $HAS $HBAN $HCA $MNPR $MODG $MSO $NOW"
X Link @Newbie_AAA 2025-12-08T19:32Z XX followers, XXX engagements

"for data since NXP-800 failed because if NXP-900 works it doesn't matter if they buy at $X or $XX or $XX - it's still a home run. But at $X the potential for $NVCT is similar to $AXSM and $MNPR in terms of returns. Now management must deliver"
X Link @kjerath 2025-12-03T13:59Z XXX followers, XXX engagements

$mnpr
/topic/$mnpr